Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial.
about
Ventricular pacing - Electromechanical consequences and valvular functionEuropean Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm SocietyThe importance of avoiding unnecessary right ventricular pacing in clinical practiceCardiac resynchronization therapy in heart failure patients with less severe left ventricular dysfunction2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm AssociComparison of the rhythm control treatment strategy versus the rate control strategy in patients with permanent or long-standing persistent atrial fibrillation and heart failure treated with cardiac resynchronization therapy - a pilot study of CardiHybrid therapy in the management of atrial fibrillation.Current Evidence and Recommendations for Cardiac Resynchronisation Therapy.Predictors of sustained ventricular arrhythmias in cardiac resynchronization therapy.Atrial Fibrillation and Heart Failure: A Review of the Intersection of Two Cardiac Epidemics.Cardiac Resynchronization Therapy in Patients with Atrial Fibrillation - Worth the Effort?Management of Patients with Atrial Fibrillation: Focus on Treatment Options.Atrioventricular nodal ablation in atrial fibrillation: a meta-analysis of biventricular vs. right ventricular pacing mode.Adverse effects of long-term right ventricular apical pacing and identification of patients at risk of atrial fibrillation and heart failure.Cardiac resynchronization and atrial fibrillation: what's new?2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management.Current role of atrioventricular junction (AVJ) ablation.Almanac 2013: cardiac arrhythmias and pacing.Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering properties.Atrial fibrillation and heart failure: intersecting populations, morbidities, and mortality.The changing landscape of cardiac pacing.The role of biventricular pacing in the prevention and therapy of pacemaker-induced cardiomyopathy.European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society.Role of Atrio-Ventricular Junction Ablation in Symptomatic Atrial Fibrillation for Optimization of Cardiac Resynchronization Therapy.After TOPCAT: What to do now in Heart Failure with Preserved Ejection Fraction.Cardiac resynchronization therapy: results, challenges and perspectives for the future.Right Ventricular Versus Biventricular Pacing for Heart Failure and Atrioventricular Block.Current treatment of heart failure with reduction of left ventricular ejection fraction.Co-Morbidities and Cardiac Resynchronization Therapy: When Should They Modify Patient Selection?Atrioventricular Junction Ablation In Atrial Fibrillation: Choosing The Right Patient And Pacing Device.Enhancing Cardiac Resynchronization Therapy for Patients with Atrial Fibrillation: The Role of AV Node Ablation.Korean Guidelines for Diagnosis and Management of Chronic Heart Failure.Age of cardiac resynchronisation therapy; cardiac resynchronisation therapy in elderly.Pacing-Induced Cardiomyopathy: "It's Tough to Make Predictions, Especially About the Future"*.Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: a meta-analysis.Will biventricular pacing replace right ventricular pacing for antibradycardia therapy?The European CRT Survey: 1 year (9-15 months) follow-up results.Atrioventricular node ablation and His bundle pacing.Regional variations in baseline characteristics of cardiac rhythm device recipients: The PANORAMA observational cohort study☆.
P2860
Q26739896-B2C7785D-3A9C-446B-9256-8A28B9778A93Q26796261-3E9BA783-7D2F-4ED5-8E28-FCD89DCC9B82Q26851233-EDB5B322-7474-4B96-AE53-8B0201C95D43Q27002918-099B67E2-A118-489C-B8A0-9363B8AAAA5AQ27341873-9CEEB05F-BB2E-4A24-BD74-606F3A35C651Q33162947-00F18106-519C-4F41-A700-8845DCDB28F0Q34812162-EC711260-5DDD-4D87-A1B7-E371D605EB97Q35168786-A76199FE-0D55-4ED6-B0FB-EDEE9579346FQ36458928-C5F2CB5A-C761-4E9B-BEDC-F11ED041D5C2Q37155195-D04A385F-55B8-4CB2-BC27-FC27108F51E6Q37495775-9D426AE0-F137-416F-BA54-BE11F7B8B5E2Q37496196-83FDA185-8688-433C-A818-D49B63A3C205Q37723881-81D3DF20-ACF1-42B0-AD26-94349EAE0E42Q37995812-79CE9949-C945-425E-AD65-572E60C88235Q37997450-5CA4A31E-D673-4E8F-A552-08415E59B87CQ38007999-E1E47719-0531-42CC-A4AF-BD5E3A1FBC6CQ38038846-661C564E-AEEF-481B-B70A-2B3C452418BFQ38053185-A02B3CBA-9117-4766-A8AB-CAB276702246Q38125860-A3AA7B7E-F6E3-4569-9A43-48A723E0976EQ38127568-84A71B35-13E9-419F-9C16-90B812B13D95Q38144996-A3544BE0-DF12-47DF-8C48-709A7F24C5F8Q38285944-4B18A147-E64A-4A3D-A5BA-5106667BF6F4Q38309666-E3AF0784-C1E1-4A6D-A82A-86149BD739B0Q38571627-DEB5A627-C349-4C4A-92DD-9767AC3A6EC2Q38790519-DDF3B12C-5148-4032-AA56-A60BB8A0ABAEQ38807777-0EE0B1B8-98E9-42F8-96F7-027B1A4BBDD9Q38826268-EE4389A3-5A48-4B10-B21E-E05F8AA13F93Q38935216-46B7EC48-B1F1-4412-96CA-61F02FAA7D23Q38965647-DF5E956B-B2C1-4D06-9918-039D2FCDE0BFQ39037093-EB16ADA4-8EFC-4D81-920F-A73E009AA79DQ39037120-F4B21193-FBAB-4B1C-BE79-03300B879083Q39300806-D448649F-66C6-4EDE-A755-097008C94981Q41686228-8BCDAF4D-7CDE-4CBA-84BC-C32402999098Q42328754-F9DD3316-E06D-4CF2-A539-05532909DED4Q43426842-C42E9A36-01A2-4E07-8CED-781AFFDA7653Q44163125-B5D273DF-7DD8-4B2E-AF6A-60AC3AA7A8C9Q45255850-7D61DA3B-376E-4BD4-BB3E-69EB632B0D45Q46029893-B4EDC987-873D-40EB-819F-27CA756B2D64Q47197450-1EB37088-9A12-4E5B-86DC-6E36E5F8F634Q49452368-A9E13635-F7BF-42A6-910E-9B143854249F
P2860
Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Cardiac resynchronization ther ...... rillation: a randomized trial.
@en
Cardiac resynchronization ther ...... rillation: a randomized trial.
@nl
type
label
Cardiac resynchronization ther ...... rillation: a randomized trial.
@en
Cardiac resynchronization ther ...... rillation: a randomized trial.
@nl
prefLabel
Cardiac resynchronization ther ...... rillation: a randomized trial.
@en
Cardiac resynchronization ther ...... rillation: a randomized trial.
@nl
P2093
P2860
P356
P1476
Cardiac resynchronization ther ...... brillation: a randomized trial
@en
P2093
Alessandro Navazio
Carlo Menozzi
Daniele Oddone
Gianluca Botto
Giuseppe De Marchi
Jose M Tolosana
Mario Luzi
Michele Brignole
Saverio Iacopino
P2860
P304
P356
10.1093/EURHEARTJ/EHR162
P50
P577
2011-05-23T00:00:00Z